158 related articles for article (PubMed ID: 34631744)
21. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis.
Sehgal IS; Choudhary H; Dhooria S; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
Mycoses; 2018 Oct; 61(10):770-776. PubMed ID: 29920796
[TBL] [Abstract][Full Text] [Related]
23. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study.
Lee MR; Huang HL; Chen LC; Yang HC; Ko JC; Cheng MH; Chong IW; Lee LN; Wang JY; Dimopoulos G
Clin Microbiol Infect; 2020 Aug; 26(8):1091.e1-1091.e7. PubMed ID: 31901491
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and prognosis of chronic pulmonary aspergillosis.
Ohba H; Miwa S; Shirai M; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
Respir Med; 2012 May; 106(5):724-9. PubMed ID: 22349065
[TBL] [Abstract][Full Text] [Related]
26. Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis.
Li H; Liu L; Zhou W; Rui Y; He B; Shi Y; Su X
Clin Microbiol Infect; 2019 Apr; 25(4):504-510. PubMed ID: 29964232
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.
Ohara S; Tazawa Y; Tanai C; Tanaka Y; Noda H; Horiuchi H; Usui K
Respir Investig; 2016 Mar; 54(2):92-7. PubMed ID: 26879478
[TBL] [Abstract][Full Text] [Related]
28. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
29. Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study.
Ibrahim W; Wilde M; Cordell R; Salman D; Ruszkiewicz D; Bryant L; Richardson M; Free RC; Zhao B; Yousuf A; White C; Russell R; Jones S; Patel B; Awal A; Phillips R; Fowkes G; McNally T; Foxon C; Bhatt H; Peltrini R; Singapuri A; Hargadon B; Suzuki T; Ng LL; Gaillard E; Beardsmore C; Ryanna K; Pandya H; Coates T; Monks PS; Greening N; Brightling CE; Thomas P; Siddiqui S
BMJ Open; 2019 Mar; 9(3):e025486. PubMed ID: 30852546
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a quantitative serum Aspergillus fumigatus-specific IgM assay for diagnosis of chronic pulmonary aspergillosis.
Yao Y; Zhou H; Shen Y; Yang Q; Ye J; Fu Y; Lu G; Lou H; Yu Y; Zhou J
Clin Respir J; 2018 Nov; 12(11):2566-2572. PubMed ID: 30191673
[TBL] [Abstract][Full Text] [Related]
31. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
32. Prospective Evaluation of a New Aspergillus IgG Enzyme Immunoassay Kit for Diagnosis of Chronic and Allergic Pulmonary Aspergillosis.
Dumollard C; Bailly S; Perriot S; Brenier-Pinchart MP; Saint-Raymond C; Camara B; Gangneux JP; Persat F; Valot S; Grenouillet F; Pelloux H; Pinel C; Cornet M
J Clin Microbiol; 2016 May; 54(5):1236-42. PubMed ID: 26888904
[TBL] [Abstract][Full Text] [Related]
33. Gastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
Gamaletsou MN; Denning DW
Mycopathologia; 2017 Dec; 182(11-12):1125-1129. PubMed ID: 28702854
[TBL] [Abstract][Full Text] [Related]
34. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.
Phillips CO; Syed Y; Parthaláin NM; Zwiggelaar R; Claypole TC; Lewis KE
J Breath Res; 2012 Sep; 6(3):036003. PubMed ID: 22759349
[TBL] [Abstract][Full Text] [Related]
35. Screening for emphysema via exhaled volatile organic compounds.
Cristescu SM; Gietema HA; Blanchet L; Kruitwagen CL; Munnik P; van Klaveren RJ; Lammers JW; Buydens L; Harren FJ; Zanen P
J Breath Res; 2011 Dec; 5(4):046009. PubMed ID: 22071870
[TBL] [Abstract][Full Text] [Related]
36. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA).
Page ID; Richardson MD; Denning DW
J Infect; 2016 Feb; 72(2):240-9. PubMed ID: 26680697
[TBL] [Abstract][Full Text] [Related]
37. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
38. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
39. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
40. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus.
Chambers ST; Bhandari S; Scott-Thomas A; Syhre M
Med Mycol; 2011 Apr; 49 Suppl 1():S54-61. PubMed ID: 20795766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
